The story goes that the services business ate the insurer. Read the eliminations line in the filing, and you find the insurer quietly feeding the business it supposedly lost to.

Pairs with the Cross-Subsidy Map — a ready-to-use strategy tool. Included in the The Cross-Subsidy Casebook →

In 2011, UnitedHealth Group gathered a pile of unglamorous back-office businesses — a data shop called Ingenix, a pharmacy-benefits operation, a grab-bag of clinics and care services — and gave them a single, forward-sounding name: Optum.1 At the unveiling the company called it a '$27 billion information and technology-enabled health services business platform,' with more than 30,000 employees and a new CEO.2 Fifteen years later, the standard narrative is that this platform grew up, ate its vegetables, and overtook the insurer that raised it. It's a great story. The company's own filings quietly disagree.

The official story is that Optum became the engine and UnitedHealthcare became the passenger. Look at the segment lines UnitedHealth reports to the SEC and the opposite is true: the insurer still earns more revenue, still books more operating profit in the periods where the two can be compared, and — the part almost nobody mentions — is quietly buying a huge slice of Optum's own reported sales. Optum didn't overtake the insurer. It got fed by it.

The rebrand that everyone remembers as a coronation: what got announced in 2011 was a name, not a changing of the guard

On April 11, 2011, UnitedHealth said its health services businesses would 'now align their market engagement under the Optum brand,' pointing to $25 billion in combined 2010 revenue and more than 60 million people served.3 It was a real business — but it was also a marketing act. Three sprawling units got a coherent story and a leadership team, and Wall Street got something clean to root for.2 Growth from there was genuine and fast: Optum crossed $100 billion in annual revenue for the first time in 2018, up more than 11% to $101.3 billion.5 Somewhere in that arc the shorthand hardened into legend — the tech-enabled services arm had surpassed the boring old HMO. The legend skips a step. Optum grew enormously and still never pulled ahead of the insurer on the numbers that matter.

Optum's genesis, in the company's own words
$25B
Combined 2010 revenue of the businesses unified under Optum3
$27B
The platform's size at its formal 2011 unveiling2
14.8%
Optum's share of group operating earnings in 20114
$101.3B
Optum revenue in 2018 — its first year past $100B5

Follow the segment lines and the insurer never lost the lead: on both revenue and profit, UnitedHealthcare stays ahead in every period you can compare

Here is where the story cracks — though every segment figure that follows, including UnitedHealthcare's, is a gross number that is not separately stripped of that segment's own intercompany sales, so this is a same-basis comparison rather than a clean read on external, third-party revenue alone. In the first quarter of 2023, UnitedHealthcare's segment revenue was $70.5 billion against Optum's $54.1 billion — and on profit, the insurer earned $4.3 billion versus Optum's $3.7 billion.6 Optum was growing faster, yes: 25% to the insurer's 13%.6 But faster growth off a smaller base is not overtaking; it is catching up, at best. For full-year 2023 the gap was wider still: UnitedHealthcare $281.4 billion, Optum $226.6 billion.7 And by the first quarter of 2026 — fifteen years after the rebrand — the insurer posted $86.3 billion in revenue with operating earnings up 9% to $5.7 billion, while Optum came in at $63.7 billion.11 The one profit statistic the legend leans on is Optum's rising share of group earnings: 14.8% in 2011, climbing to 44% by 2017.4 But 44% is not a majority. It's the story of a strong number two, told as if it were the crown.

UnitedHealthcareOptum
Q1 2023 segment revenue$70.5B$54.1B
Q1 2023 operating earnings$4.3B$3.7B
FY2023 revenue$281.4B$226.6B
Q1 2026 revenue$86.3B$63.7B
The verdictStill aheadStill behind
Optum vs. UnitedHealthcare, in the periods you can compare directly

The number the profile pieces never quote: much of Optum's scale is Optum selling to its own sister insurer

Now the mechanism — the why beneath the misread. When a company owns both the buyer and the seller, it has to erase the sales between them before reporting a consolidated total, because a dollar the left pocket pays the right pocket isn't new money entering the firm. UnitedHealth labels that erasure 'corporate eliminations.' In 2023 it was $136.4 billion. In 2024 it was $150.9 billion.9 Sit with the scale of that: Optum's own segment disclosures show $150.9 billion of 2024 revenue booked from 'affiliated customers' — a figure that matches the corporate-eliminations line almost exactly and equals nearly 60% of Optum's entire reported revenue, while UnitedHealthcare discloses essentially no affiliated-customer revenue of its own.10 Because UnitedHealthcare discloses essentially no revenue of its own from affiliated customers, that flow runs almost entirely one way: Optum billing UnitedHealthcare — the group's pharmacy manager filling the group's health-plan prescriptions, the group's clinics treating the group's members, the group's data arm serving the group's insurer.10 Strip out the family transactions and Optum's true third-party heft is far smaller than its headline revenue suggests. Its scale isn't only won in the open market. A great deal of it is manufactured in-house.

$150.9B
of intercompany sales UnitedHealth erased on consolidation in 2024 — money Optum billed to its own sister insurer, roughly the size of Optum's entire reported revenue9

That is the definition of a cross-subsidy dressed as a growth story. The insurer collects premiums from tens of millions of members, then routes an enormous stream of that spending into its own services arm — pharmacy, care, analytics — and books it as Optum's revenue. The captive customer is the sister company. This is why Optum's chart looks like a rocket while UnitedHealthcare's looks like a utility: one segment is being fed by a firehose the other one controls. Optum is genuinely large and genuinely good at what it does. But the same corporate roof that lets it look like the future is the roof that supplies most of its demand.

Isn't a captive customer still real profit?: the honest counter is that internal sales create value too — the question is who's the engine

The fair objection: intercompany revenue is not fake. When Optum manages UnitedHealthcare's pharmacy spend or runs its clinics, real work is done, real costs are lowered, and real margin is captured that would otherwise leak to an outside vendor. Vertical integration is a legitimate strategy, and Optum's rise as an integrator is a genuine competitive edge — the reason it was called 'a step ahead' in the industry's consolidation race.4 All true. But notice what it doesn't establish. That Optum captures value from serving the insurer is precisely the point: the value originates in the insurance flow. You cannot simultaneously argue that Optum is the independent engine that overtook the insurer and that its scale comes from serving that insurer. The cross-subsidy story doesn't diminish Optum — it correctly locates the source of its power. The premium dollars come in the front door as insurance. Some of them walk down the hall and get counted a second time as services.9 Two segments, one wallet.

When one segment sells to another, read the eliminations line first

A vertically integrated company can make any internal division look like a breakout business simply by routing spending through it — the revenue is real on that segment's page and vanishes on the consolidated one. Before you believe that a services arm 'overtook' the core, find the intercompany-eliminations figure in the filing and compare it to the arm's reported revenue. If the two are the same order of magnitude, you are not looking at a market winner. You are looking at a captive customer, and the real engine is whoever controls the demand. The growth chart is telling you about the plumbing, not the market.

Optum was born as a name in 2011 and grew into one of the largest health-services businesses on earth. That much is true and impressive. What isn't true is the coronation. In every period UnitedHealth lets you compare, the insurer still earns more, and the services arm that supposedly dethroned it turns out to draw most of its scale from the throne itself.6119 The interesting question was never which sibling is bigger. It's that a single company built a machine where the answer can be honestly reported both ways — and chose to let the world remember the flattering version.

Take it with you — The Cross-Subsidy
Map

Cross-Subsidy Map

A map of the hidden plumbing inside a multi-line business: the cash-cow donor, the loss-making recipient it props up, and the strategic reason the subsidy exists. Use it to see who is really paying for what, and how exposed the whole structure is if the donor weakens. Blank to map your own portfolio's internal transfers; filled as the worked example of a business where one line secretly carries another.

Blank template

Included, filled and blank, in the The Cross-Subsidy Casebook. See the set → · Preview the blank →

Sources

Where this comes from — the filings, records, and reporting behind it.

  1. 1
    Primary · SEC filingDocumented
    UnitedHealth Group's services businesses began operating under the master Optum brand effective in 2011, with OptumHealth (unchanged), OptumInsight (formerly Ingenix), and OptumRx (formerly Prescription Solutions); the company began reporting under this new structure starting with its 10-Q for the quarter ended March 31, 2011.
  2. 2
    Primary · SEC filingDocumented
    At its formal unveiling, Optum was described by UnitedHealth Group as its '$27 billion information and technology-enabled health services business platform,' with its three units — OptumHealth, OptumInsight and OptumRx — employing more than 30,000 people worldwide, under new CEO Larry Renfro (named July 6, 2011).
  3. 3
    Primary · Company recordDocumented
    UnitedHealth Group announced on April 11, 2011 that its health services businesses would unify under the master brand Optum, with CEO Stephen Hemsley stating the health services businesses would 'now align their market engagement under the Optum brand'; the combined businesses reported 2010 combined revenues of $25 billion and served more than 60 million people.
  4. 4
    PublishedAttributed to source
    In 2011, the first year Optum was configured as it looks today, it contributed 14.8% of UnitedHealth Group's total earnings from operations, or $1.26 billion; by 2017, Optum's share had grown to 44% of UnitedHealth Group's profits.
  5. 5
    PublishedDocumented
    Optum's annual revenue surpassed $100 billion for the first time in fiscal year 2018, growing 11.1% year-over-year to $101.3 billion, while UnitedHealthcare's fourth-quarter 2018 revenue alone was $46.2 billion, up 11.1% — confirming the insurer remained on a larger revenue base than the services arm even as Optum crossed the $100B threshold.
  6. 6
    Primary · SEC filingDocumented
    In first quarter 2023, UnitedHealthcare segment revenues grew 13% to $70.5 billion with operating earnings of $4.3 billion, compared to Optum segment revenues of $54.1 billion (up 25%) and operating earnings of $3.7 billion — UnitedHealthcare outsold and outearned Optum on a like-for-like segment basis.
  7. 7
    PublishedDocumented
    For full year 2023, UnitedHealth Group's insurance arm UnitedHealthcare posted $281.4 billion in revenue (up 12.7% year-over-year), while Optum's full-year revenues were $226.6 billion (up 24% from 2022); Optum's 2022 revenue base of $182.8 billion (up 17%, or $27.2 billion) was independently reported the same way in Forbes's coverage of UnitedHealth's Q4 2022 results — corroborating that UnitedHealthcare's revenue lead over Optum persisted through at least 2023.
  8. 8
    PublishedDocumented
    As of first quarter 2026, UnitedHealthcare posted $86.3 billion in total revenue with operating earnings rising 9% to $5.7 billion, while Optum reported $63.7 billion in total revenue for the same quarter — fifteen years after the Optum brand's creation, UnitedHealthcare's revenue and operating-earnings lead over Optum remains intact.
  9. 9
    Primary · SEC filingDocumented
    UnitedHealth Group's own reported financials show 'corporate eliminations' — intercompany revenue between Optum and UnitedHealthcare stripped out on consolidation — of $136.4 billion for 2023 and $150.9 billion for 2024, indicating that a very large share of Optum's gross activity consists of internal sales back to its sister insurance segment rather than external, third-party revenue.
  10. 10
    Primary · SEC filingDocumented
    Optum's segment disclosures show $150,887 million (2024) / $136,373 million (2023) of revenue from 'affiliated customers' — matching the corporate-eliminations line almost exactly — while UnitedHealthcare's own 'affiliated customers' revenue line is reported as zero, establishing that the eliminated intercompany revenue runs overwhelmingly from Optum to UnitedHealthcare rather than being an evenly bidirectional netting.
  11. 11
    Primary · SEC filingDocumented
    UnitedHealthcare's first-quarter 2026 revenue was $86.3 billion, with operating earnings of $5.7 billion, while Optum's first-quarter 2026 revenue was $63.7 billion.

More like this — beyond UnitedHealth Group

New Strategically analyses as they publish: the defining moves in business, checked against the record. No noise, and one click to leave.